{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-002017","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.722752+00:00","generated_at":"2026-06-08T22:10:33.288703+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lexaria Bioscience regains Nasdaq bid price compliance; warrant exercises yield $444,895","bullets":["Received Nasdaq letter on Nov 3, 2023 confirming cure of $1.00 minimum bid price deficiency after 11 consecutive days above $1.00 (Oct 19 - Nov 2).","Since Oct 24, 2023, exercised warrants for 468,279 shares at $0.95/share, generating gross proceeds of $444,865.","Pre-funded warrants exercised for 303,058 shares at $0.0001/share, generating gross proceeds of $30.31.","Total common shares outstanding after these exercises: 9,752,259."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-002017","json":"https://secwatch.observer/filing/0001640334-23-002017.json","markdown":"https://secwatch.observer/filing/0001640334-23-002017.md","text":"https://secwatch.observer/filing/0001640334-23-002017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/0001640334-23-002017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423002017/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:10:33.288703+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}